Basic Information
RNALocate ID: RLID:11004120
RNA Symbol: hsa-miR-708-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-708-5p
RNA ID: miRBase:MIMAT0004926
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002694 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002695 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:11004121 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000717 Microvesicle Fibroblasts|Mesenchymal stem cells
RLID-D:11001599 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-708-5p Oral squamous cell carcinoma MNDR-E-MI-68056
MNDR hsa-miR-708-5p Small intestinal neuroendocrine tumor MNDR-E-MI-68057
MNDR hsa-miR-708-5p High-grade serous ovarian carcinoma MNDR-E-MI-68058
MNDR hsa-miR-708-5p Ovarian clear cell carcinoma MNDR-E-MI-68059
MNDR hsa-miR-708-5p Lymphoma MNDR-E-MI-68060
MNDR hsa-miR-708-5p Estrogen-receptor positive breast cancer MNDR-E-MI-68061
MNDR hsa-miR-708-5p Estrogen-receptor negative breast cancer MNDR-E-MI-68062
MNDR hsa-miR-708-5p Progesterone-receptor positive breast cancer MNDR-E-MI-68063
MNDR hsa-miR-708-5p Progesterone-receptor negative breast cancer MNDR-E-MI-68064
MNDR hsa-miR-708-5p Her2-receptor positive breast cancer MNDR-E-MI-68065
MNDR hsa-miR-708-5p Breast cancer luminal MNDR-E-MI-68066
MNDR hsa-miR-708-5p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-68067
MNDR hsa-miR-708-5p B cell acute lymphoblastic leukemia MNDR-E-MI-68068
MNDR hsa-miR-708-5p Small intestine cancer MNDR-E-MI-68069
MNDR hsa-miR-708-5p Prostate cancer MNDR-E-MI-68070
MNDR hsa-miR-708-5p Chronic lymphocytic leukemia MNDR-E-MI-68071
MNDR hsa-miR-708-5p Gastric cancer MNDR-E-MI-68072
MNDR hsa-miR-708-5p Alzheimer disease MNDR-E-MI-68073
MNDR hsa-miR-708-5p Urinary bladder cancer MNDR-E-MI-68074
MNDR hsa-miR-708-5p Esophageal carcinoma MNDR-E-MI-68075
MNDR hsa-miR-708-5p Dysautonomia familial MNDR-E-MI-68076
MNDR hsa-miR-708-5p Graves disease MNDR-E-MI-68077
MNDR hsa-miR-708-5p Leukemia MNDR-E-MI-68078
MNDR hsa-miR-708-5p Huntington disease MNDR-E-MI-68079
MNDR hsa-miR-708-5p Lung cancer MNDR-E-MI-68080
MNDR hsa-miR-708-5p Parkinson disease MNDR-E-MI-68081
MNDR hsa-miR-708-5p Primary pulmonary hypertension MNDR-E-MI-68082
MNDR hsa-miR-708-5p Basal-like breast cancer MNDR-E-MI-68083
MNDR hsa-miR-708-5p Cancer MNDR-E-MI-68084
MNDR hsa-miR-708-5p Thyroid cancer MNDR-E-MI-68085
MNDR hsa-miR-708-5p Pancreatic cancer MNDR-E-MI-68086
MNDR hsa-miR-708-5p Rectum adenocarcinoma MNDR-E-MI-68087
MNDR hsa-miR-708-5p Nephroblastoma MNDR-E-MI-68088
MNDR hsa-miR-708-5p Colon cancer MNDR-E-MI-68089
MNDR hsa-miR-708-5p Colon adenocarcinoma MNDR-E-MI-68090
MNDR hsa-miR-708-5p Relapsing-remitting multiple sclerosis MNDR-E-MI-68091
MNDR hsa-miR-708-5p Prostate adenocarcinoma MNDR-E-MI-68092
MNDR hsa-miR-708-5p Laryngeal neoplasms MNDR-E-MI-68093
MNDR hsa-miR-708-5p Endometriosis MNDR-E-MI-68094
MNDR hsa-miR-708-5p Carcinoma ductal breast MNDR-E-MI-68095
MNDR hsa-miR-708-5p Glioblastoma MNDR-E-MI-68096
MNDR hsa-miR-708-5p Amyotrophic lateral sclerosis MNDR-E-MI-68097
MNDR hsa-miR-708-5p Ewing sarcoma MNDR-E-MI-68098
MNDR hsa-miR-708-5p Gastric adenocarcinoma MNDR-E-MI-68099
MNDR hsa-miR-708-5p Lung squamous cell carcinoma MNDR-E-MI-68100
MNDR hsa-miR-708-5p Carcinoma lung non-small-cell MNDR-E-MI-68101
MNDR hsa-miR-708-5p Lung adenocarcinoma MNDR-E-MI-68102
MNDR hsa-miR-708-5p Thyroid carcinoma MNDR-E-MI-68103
MNDR hsa-miR-708-5p Ovarian carcinoma MNDR-E-MI-68104
MNDR hsa-miR-708-5p Bladder urothelial carcinoma MNDR-E-MI-68105
MNDR hsa-miR-708-5p Pancreatic adenocarcinoma MNDR-E-MI-68106
MNDR hsa-miR-708-5p Carcinoma renal cell MNDR-E-MI-68107
MNDR hsa-miR-708-5p Kidney renal papillary cell carcinoma MNDR-E-MI-68108
MNDR hsa-miR-708-5p Renal clear cell carcinoma MNDR-E-MI-68109
MNDR hsa-miR-708-5p Biliary tract cancer MNDR-E-MI-68110
MNDR hsa-miR-708-5p Cholangiocarcinoma MNDR-E-MI-68111
MNDR hsa-miR-708-5p Esophageal cancer MNDR-E-MI-68112
MNDR hsa-miR-708-5p Synovial sarcoma MNDR-E-MI-68113
MNDR hsa-miR-708-5p Head and neck squamous cell carcinoma MNDR-E-MI-68114
MNDR hsa-miR-708-5p Breast invasive carcinoma MNDR-E-MI-68115
MNDR hsa-miR-708-5p Hepatocellular carcinoma MNDR-E-MI-68116
MNDR hsa-miR-708-5p Hodgkin lymphoma MNDR-E-MI-68117
MNDR hsa-miR-708-5p Colorectal cancer MNDR-E-MI-68118
MNDR hsa-miR-708-5p Nasopharynx carcinoma MNDR-E-MI-68119
MNDR hsa-miR-708-5p Multiple myeloma MNDR-E-MI-68120
MNDR hsa-miR-708-5p Nasopharyngeal cancer MNDR-E-MI-68121
MNDR hsa-miR-708-5p Prostatic neoplasms MNDR-E-MI-68122
MNDR hsa-miR-708-5p Aids dementia complex MNDR-E-MI-68123
MNDR hsa-miR-708-5p Subarachnoid hemorrhage traumatic MNDR-E-MI-68124
MNDR hsa-miR-708-5p Breast cancer her3+ negative MNDR-E-MI-68125
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AKT1 Homo sapiens RR00067020
TOP